E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/6/2006 in the Prospect News Biotech Daily.

Fitch rates Boston Scientific notes BBB

Fitch Ratings said it has assigned a rating of BBB to Boston Scientific Corp.'s planned $1.2 billion senior unsecured note issue.

In addition, Fitch said it has affirmed Boston Scientific's issuer default rating at BBB, senior unsecured notes at BBB, unsecured bank credit facility at BBB and commercial paper at F2.

The outlook is stable.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.